Tracer library / [68Ga]Ga-Trivehexin

[68Ga]Ga-Trivehexin

Also written as [68Ga]Ga-Trivehexin

Radionuclide: Ga-68
Modality: —
Production route: —
Stage: Clinical research
Syntheses indexed: 1

What it is

Compound class: Peptide (trimeric αvβ6-integrin-targeting ligand)
Target / mechanism: αvβ6-integrin PMID 38717591
Clinical application: PET imaging of carcinomas / various malignant cancers PMID 38717591
Theranostic pair: —

Published syntheses

Module	Cassette	Purification	Yield %	RCP %	Precursor / supplier	Source
iQS-TS ITG (Isotope Technologies Garching)	vendor cassette	SPE	75.7 ± 5.4%	99.79%	Trivehexin CSBio, California, US	39156699 2024 Front Oncol module iQS-Theranostics Synthesizer (iQS-TS) — higher RCY of 72.4 ± 4.2% and 75.7 ± 5.4% appeared at pH 2.9 and 3.6, respectively

Precursor

Common precursor: —
Suppliers seen in the literature: —
Cited suppliers in indexed syntheses: CSBio
Typical final purification: —

Need this precursor?We can point you to suppliers for [68Ga]Ga-Trivehexin, or handle the enquiry for you.

Get in touch

Notes

Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 2 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 38717591, 39156699. Stage set/updated at stage 39 from PMID 38717591: '68Ga-Trivehexin is an investigational PET radiopharmaceutical (NCT05799274) targeting αvβ6-integrin for PET imaging of carcinomas.'.